GlassScriptPhysician profile
Vavah Fiase
NPI 1013447952
$2,432.25
in general payments reported to CMS, 2019-2025
20 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $639 · 2024: $1,400 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $91.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $430.17 | 2023-2025 | Gemtesa, Myfembree |
| Novo Nordisk INC | $241.62 | 2024 | Wegovy |
| Gilead Sciences, INC. | $218.52 | 2024 | Trodelvy, Veklury |
| Alexion Pharmaceuticals, INC. | $211.82 | 2024 | Ultomiris |
| Convatec INC. | $208.41 | 2023-2025 | |
| Inari Medical, INC. | $159.56 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ferring Pharmaceuticals INC. | $125.00 | 2025 | Adstiladrin |
| Daiichi Sankyo INC. | $123.80 | 2024 | Vanflyta |
| Inspire Medical Systems, INC. | $119.56 | 2024 | Inspire |
| Abbvie INC. | $116.40 | 2024 | |
| Sanofi Pasteur INC. | $97.96 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.19 | 2025 | Xifaxan |
| Teleflex LLC | $77.28 | 2023-2025 | Urolift |
| Dentsply Ih Ab | $68.38 | 2023 | Lofric |
| 180 Medical, INC. | $38.72 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29.96 | 2023 | Lithovue |
| Medtronic, INC. | $23.33 | 2025 | Interstim |
| Avation Medical, INC. | $21.11 | 2025 | Vivally System |
| Coloplast Corp | $18.06 | 2024 | |
| Genmab U.S., INC. | $16.40 | 2024 | Tivdak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vavah Fiase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.